Is Amneal Pharmaceuticals, Inc. overvalued?

Amneal Pharmaceuticals, Inc. (AMRX) looks undervalued — trading about 76% below its fair value.

Undervalued

Price

$17.27

Fair value

$30.33

Current P/E

19.2

Normal P/E

33.7

Market cap

$5.51B

Dividend yield

0.0%

Return on equity

-326.8%

Sector

Healthcare

Fair value compares AMRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks